FDA Regulatory Agenda Includes “Complete Response” Rule, E-Drug Listing
Executive Summary
A notice of proposed rulemaking for FDA's "complete response" regulation is scheduled for publication in July, according to HHS' semiannual regulatory agenda published in the June 28 Federal Register